2023
- BLOG: This Week in HD Research
- BLOG: Disability Tips
- The HDSA Podcast Episode #2
- Teva Announces FDA Approval of AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, a New Once-Daily Formulation of AUSTEDO® (deutetrabenazine) Tablets
- HDBuzz: Roche Phase II GENERATION HD2 study underway
- Huntington’s Disease Society of America Awards More Than $2 Million To Expand HDSA Centers of Excellence Network to Sixty-Seven Sites Across the US
- Louise Vetter provides statement in support of the FDA Listening Session on Juvenile Onset Huntington’s Disease
- HDSA Publishes 2022 Year in Review Magazine
- Introducing The HDSA Podcast
- Roche-Genentech Community Letter: GENERATION HD2 study now open
- 38th Annual HDSA Convention in New Orleans Registration Now Open